The Antimicrobial Stewardship Committee at Harbor-UCLA Medical Center has been awarded Gold status by the California Department of Public Health (CDPH), reserved for programs that demonstrate exemplary practices and have impactful community outcomes. Dr. Amy Kang, an Assistant Professor of Pharmacy Practice, secured this award as the co-chair of the committee at Harbor-UCLA Medical Center.
Melinta Theraputics has awarded an Industry Grant to Dr. Gary Fong for his proposal, “Identifying the Need and Potential Role for a Novel Long-Acting Antifungal in a Diverse, Underserved Population“ , totaling $19,836. Dr. Fong will be working alongside his Co-Principal Investigator Dr. Scott Filler, Professor of Medicine at David Geffen School of Medicine at
Dr. Jason Yamaki and Dr. Sherif Elshahawi have been honored with the 2024 CUSP Collaboration Award for their innovative research proposal, “Developing Drug Leads to Inhibit C. difficile Bacterial Infection.” The research aims to open more opportunities for discovering solutions in antibiotic resistance for infectious disease treatments. The CUSP Collaboration Award is designed to foster
Dr. Amy Kang has been awarded the inaugural CUSP Patient Safety Award for her proposal “Addressing the Silent Threat: Inappropriate Diagnosis and Management of Urinary Tract Infection in Outpatient Settings.” Following reviews of CUSP’s Science and Patient Safety Committees, award recognizes a faculty member’s innovative research proposals that show potential to significantly improve patient care.
Dr. Caitlin Calhoun, Doctor of Pharmacy ’21, was recognized as a recipient of the 2024 Miltenyi Biotec Immunology Innovator Award for her work in improving pediatric patient outcomes of high risk leukemias through biomarker discoveries. Currently serving as a Staff Scientist at Children’s Hospital of Orange County, Dr. Calhoun is passionate about improving children’s health
Dean Ren Ostrom recently provided his expertise in Verywell Health, a publication that reaches over 300 million readers annually. Dr. Ostrom discussed at length the implications of a recent study published in the New England Journal of Medicine regarding the necessity of beta-blockers for heart attack patients with preserved heart function. Dr. Ostrom emphasized the
Through a unique offering of education and collaboration, the 3rd Annual Pacific Coast Patient Safety Conference (PCPSC) brought together a record number of healthcare professionals for its 2024 conference in San Diego, California. Hosted as a boutique conference experience, the PCPSC attracted a diverse audience, including physicians, nurses, and pharmacists, seeking quality programming, networking, and
Dialing in on years 2018-2021, Chapman University faculty have begun to bridge the data gap in understanding data trends on how buprenorphine was prescribed to both insured and uninsured patients in California. Contrary to past findings that relied on data to insured patients, the study “Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic